Anthony Dailley, Director at NovaBay Pharmaceuticals, Inc. (NBY), bought 3,000 shares at $2.75 ($8K) on 2008-03-14, disclosed to the SEC on 2008-03-18.
Open-market purchase of $8k NBY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.